| 标题 |
Targeting homologous recombination deficiency with intensified chemotherapy versus standard chemotherapy followed by olaparib in stage III breast cancer (SUBITO): an open-label, randomised, controlled, phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncology 作者:Rianne Seefat; S.B. Vliek; Vincent M T de Jong; Sara Balduzzi; Ingrid A.M. Mandjes; et al 出版日期:2026-06-29 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)